The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Colitis-associated cancer (CAC) is a major complication of inflammatory bowel diseases. We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models. Mice lacking the inflammasome adaptor protein PYCARD (ASC) and caspase-1 demonstrate increased disease outcome, morbidity, histopathology, and polyp formation. The increased tumor burden is correlated with attenuated levels of IL-1beta and IL-18 at the tumor site. To decipher the nucleotide-binding domain, leucine-rich-repeat-containing (NLR) component that is involved in colitis and CAC, we assessed Nlrp3 and Nlrc4 deficient mice. Nlrp3(-/-) mice showed an increase in acute and recurring colitis and CAC, although the disease outcome was less severe in Nlrp3(-/-) mice than in Pycard(-/-) or Casp1(-/-) animals. No significant differences were observed in disease progression or outcome in Nlrc4(-/-) mice compared with similarly treated wild-type animals. Bone marrow reconstitution experiments show that Nlrp3 gene expression and function in hematopoietic cells, rather than intestinal epithelial cells or stromal cells, is responsible for protection against increased tumorigenesis. These data suggest that the inflammasome functions as an attenuator of colitis and CAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies using different mice deficient for inflammasomes components (including NLRP3, NLRP1, NLRP6, NLRC4 and Caspase-1) found that the inflammasomes protect mice from colitis-associated CRC [120,121,122,123,124].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commensal bacteria and their bioproducts induce inflammasomes activation and IL-18 production in the gut, which, in turn, prevents intestinal barrier disruption and dysbiosis [121,124,131,132,133].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [121]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952 · cited 2×
“Two families of innate immune receptors, the Tolllike receptors (TLRs) and the nu cleotidebinding domain, leucinerichrepeat containing (NLR) proteins, have emerged as essential mediators of gastrointestinal inflam mation and homeostasis (Akira et al., 2006; Franchi et al., 2006).”
BackgroundGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326 · cited 4×
“How ever, damage to the colonic epithelial cell layer in the colon initiates the release of various DAMP signals, and DAMPs have the potential to activate the NLRP3 inflam masome.”
BackgroundInfluentialA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · cited 6×
“Jenny P.-Y. Ting: panyun@med.unc.edu Abbreviations used: AOM, azoxymethane; ASC/ PYCARD, Apoptotic Speck protein containing a CARD; CAC, colitisassociated cancer; CRC, colorectal cancer; DAMP, damageassociated molecular pattern; DSS, dextran sulfate sodium; HAI, Histologi cal Activity Index; IBD, inflam matory bowel d…”
BackgroundInfluentialRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 2×
“AIM2 has been shown to form of commensal normal flora in the intestine (RakoffNahoum et al., 2004; Araki et al., 2005; Fukata et al., 2005).”
BackgroundThe risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959 · cited 1×
“Patients suffering from UC demonstrate a significantly increased risk of colorectal cancer (CRC), which seems to be associated with both the duration of the disease and the degree of mucosal inflammation (Eaden et al., 2001).”
BackgroundAIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627 · cited 16×
“Organ culture supernatants were harvested after incubation for 24 h and IL1, IL18, and TNF levels were determined by ELISA.”
InfluentialIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041 · cited 2×
“…functional Nlrp3, Nlrc4, Pycard, and caspase1 (Casp1) has been previously described (R. Flavell, Yale University, New Haven, CT; V. Dixit, Genentech, Inc., San Francisco, CA; F. Sutterwala, University of Iowa, Iowa City, IA; Adachi et al., 1998; Mariathasan et al., 2004; Sutterwala et al., 2006).”
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839 · cited 5×
“In ad dition to NLRP3, other NLRs, such as NLRC4, can form NLRP3independent inflammasome in response to specific stimuli, such as flagellin (Mariathasan et al., 2004).”
BackgroundInfluential
Cited by
Items 801–849 of 849
Borik Asit LPS ile Uyarılan Glioblastoma Hücrelerinde İnflamazom Aktivasyonunu İnhibe Eder
Hacıoğlu, C. (2024) · Sağlık Bilimlerinde Değer · doi:10.33631/sabd.1408373
Inverse correlation between NLRP3 and TMEM176B as a possible tool for colorectal cancer progressionPreprint
Cambui, R. A. G., Roa, M. E. V., Leal, V. N. C., Yamada, S. M., de Oliveira, L. A. T., Nadaf, I. N., Lélis, C. R., Pedroso, R. C. D. C., Costa, R. C. D. N., Amorim, R. M. N., et al. (2024) · medRxiv · doi:10.1101/2024.08.30.24312793
Structuring Inflammasome-Epigenome: Phenotypic Axis in Gynecological Cancers
Sharda, S., Avasthi, A. S., & Kaur, N. (2024) · Springer eBooks · doi:10.1007/978-981-99-6263-1_25
Wen, X., Li, W., Li, S., Chen, D., Zheng, J., Wang, X., Zhang, C., Liu, Y., Ning, Y., Jia, R., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.139307 · Cited by 1
Mészáros, Á. (2024) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.12242
Mehrabi, Z., Rahimi, Z., Mohammadi, P., Jalilian, N., Haghnazari, L., Salari, F., & Asadi, S. (2025) · Journal of International Medical Research · doi:10.1177/03000605251379519
“Research conducted by Allen et al. 14 and Wei et al. 15 has demonstrated a tumor-suppressive role of NLRP3 in colitis-associated and hepatic malignancies, respectively, highlighting the intricate and dualistic nature of inflammasome signaling in tumor biology.”
Role of NLRP3 Inflammasomes in Disorders of Children’s Digestive Systems: A Narrative Review
ELMeneza, S. (2025) · Pediatric Reports · doi:10.3390/pediatric17050103
“Mice lacking NLRP3 are more prone to dextran sodium sulfate-induced colitis [29,30,44].”
Paudel, S., Ghimire, L., Jeansonne, D. P., Cai, S., Bhattarai, D., Le, J., Taylor, C. M., & Jeyaseelan, S. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf272
Transcriptomic insights into GSDME-driven pyroptosis in head and neck cancer
Hao, F., Qin, D., Li, R., Li, X., Hou, J., & Zhao, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-30182-3
Whetstone, R. D. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Die NLRP3-abhängige Freisetzung von MRP8/14 im neutrophilen Granulozyten
Kuchler, T. (2023) · doi:10.5282/edoc.31640 · Cited by 1
Chen, F.-W., Wu, Y.-L., Cheng, C.-C., Hsiao, Y.-W., Chi, J.-Y., Hung, L.-Y., Chang, C.-P., Lai, M.-D., & Wang, J.-M. (2024) · Figshare · doi:10.6084/m9.figshare.26669988
Chen, F.-W., Wu, Y.-L., Cheng, C.-C., Hsiao, Y.-W., Chi, J.-Y., Hung, L.-Y., Chang, C.-P., Lai, M.-D., & Wang, J.-M. (2024) · Figshare · doi:10.6084/m9.figshare.26669985
Chen, F.-W., Wu, Y.-L., Cheng, C.-C., Hsiao, Y.-W., Chi, J.-Y., Hung, L.-Y., Chang, C.-P., Lai, M.-D., & Wang, J.-M. (2024) · Figshare · doi:10.6084/m9.figshare.26669994
Chen, F.-W., Wu, Y.-L., Cheng, C.-C., Hsiao, Y.-W., Chi, J.-Y., Hung, L.-Y., Chang, C.-P., Lai, M.-D., & Wang, J.-M. (2024) · Figshare · doi:10.6084/m9.figshare.26669991
The role of Necroptosis in inflammatory bowel diseases
Barbé, F. (2016) · eScholarship@McGill (McGill) · doi:10.82308/27909 · Cited by 1
Inflammasomin toiminta syövässä ja aineenvaihduntasairauksissa
Garces Ibanez, J. (2025) · UTUPub (University of Turku)
Mahato, M., Mondal, P., & Bhattacharyya, S. (2026) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-026-00528-y
木村, 好. (2016) · Institutional Repositories DataBase (IRDB) · doi:10.15083/00073854
Inflammasomes : des mécanismes d’activation de la caspase-1 à la progression tumorale
Guey, B. (2016) · theses.fr (ABES) · doi:10.70675/42ebd7a3zcde2z449czb32cz9db33732e38c · Cited by 2
“Inflammasomes form the molecular platforms that allow caspase-1 dimerization, activation, and autoproteolysis (11).”
BackgroundRôle de la caspase-1 dans les phénomènes de mort cellulaire dans le cancer colorectal
Dérangère, V. (2014) · theses.fr (ABES) · doi:10.70675/c8e9b09bz023dz42c6zba17z0ef6440a2e21
Régulation des cellules NK par le TGF-β
Viel, S. (2016) · theses.fr (ABES) · doi:10.70675/d36349aezc6afz4166z8968z40abbe3c36c2 · Cited by 1
Vétizou, M. (2015) · theses.fr (ABES) · doi:10.70675/6ad24363zc086z46fczb9dazca490b1580b3
Rôle de la pantéthéinase épithéliale Vanin-1 dans l'inflammation intestinale
Gensollen, T. (2014) · theses.fr (ABES) · doi:10.70675/4525dc6dz222cz40b2za3b8z6077ea8bed51
Bingula, R. (2019) · theses.fr (ABES) · doi:10.70675/0634dca5z63c4z42bdza47azaf2d4eb69fd8 · Cited by 1
Caspase-14 recognizes and processes IL-1β in epithelial cells to drive anti-bacterial IgG productionPreprint
Ma, M., Wang, L., & Ge, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.14.717951
Khayyat, A., Zohouri, S. A., Pour, M. A. E., Hatami, P., & Smoller, B. R. (2025) · Skin Health and Disease · doi:10.1093/skinhd/vzaf106
“30,31 While the direct effects of NLRP3 activation in skin cancers, particularly BCC and SCC, are less established, parallels can be drawn from other epithelial cancers.”
NLRP3 inflammasomes at the ARDS-cancer interface: mechanisms and translational hypotheses
Shebbo, S., Mahmoud, D. E., Alateyah, N., Hosseini, S. H., Al-Haidose, A., Ramirez, S. A., Zeidan, A., & Abdallah, A. M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1798542
Banerjee, S., & Mukhopadhyay, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40471-9.00001-x
Ghoreifi, A., Alshalalfa, M., Davicioni, E., Spratt, D. E., Karnes, R. J., Purves, J. T., Hughes, F. M., Moul, J. W., & Abern, M. R. (2026) · The Prostate · doi:10.1002/pros.70202 · Cited by 1
Jinhu, G., Li, Y., Yang, Y., & Wang, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1878878
Huang, X., Liu, W.-C.-N., & Li, D.-X. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.121010
Lin, J., Lin, H., Zhang, Z., & Wang, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1892843
Li, M., Zhang, H., Fu, R., Mao, L., Zheng, Y., Wang, L.-L., Liu, Y., Zhou, T.-T., Mu, R., Hu, H., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3367-3
Targeting inflammasome in digestive diseases: A dual approach of Western and Chinese medicine
Qi, Q., Zhu, C.-H., Li, J.-L., & Yu, J. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.121899
Gabola, M., Benzarti, M., & Letellier, E. (2026) · Seminars in Immunology · doi:10.1016/j.smim.2026.102068
Chen, Q., 张, 涵., Fu, L., Liu, F., Yang, Q., Zhang, G., Huang, Y., Yang, Y., Yao, C., Wang, Y., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198836
“…complete suppression of NLRP3 signaling may not be desirable in CAC, because NLRP3-and caspase-1-dependent IL-18 signaling has been implicated in maintaining epithelial barrier integrity and supporting anti-tumor immune surveillance in experimental colitis-associated tumorigenesis [159,161].”
Obesity-driven inflammation and immune dysregulation in cancer development and progression
Pandey, P., Struder, J. F., Rezeli, E. T., Paules, E. M., Hursting, S. D., Coleman, M. F., & Altwegg, K. A. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1947958
The Senescence-Malignancy Axis: An Inflammaging Perspective
Patrono, I., Sonnessa, M., Trerotola, M., Giudetti, A. M., Summa, S. D., Zito, F. A., Saponaro, C., & Vergara, D. (2026) · Antioxidants · doi:10.3390/antiox15101357
“Specific expression experiments demonstrate that NLRP3 protects against tumor formation through its action in hematopoietic immune cells rather than in intestinal epithelial or stromal compartments [48].”
Pyroptosis in cancer nanotherapy: Molecular mechanisms and advanced nanosystems (Review)
Abdulaal, W., Aljarba, N., Kim, B., Saadeldin, I., Alenzi, F., Abdulkhaliq, A. A., Khan, J., Borai, A., Tuomilehto, J., Lin, E., et al. (2026) · International Journal of Oncology · doi:10.3892/ijo.2026.5952
The role of NLRC5 in human inflammatory bowel diseases and murine experimental colitis
Fay, B. P., Tam, J. W., Wrobel, J. A., Huang, G., Chou, W.-C. (., Sheikh, S. Z., Furey, T. S., Sartor, R. B., Guo, H., & Ting, J. P. ‐. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag263
Self-citationCouturier-Maillard, A. (2012) · theses.fr (ABES) · doi:10.70675/0b7820f4zd2a8z4cf0zb124z58d7f3c15224 · Cited by 1
Metadata
- Authors
- Allen, I. C., TeKippe, E. M., Woodford, R.-M. T., Uronis, J. M., Holl, E. K., Rogers, A. B., Herfarth, H. H., Jobin, C., & Ting, J. P.-Y.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Lineberger Comprehensive Cancer Center 1 , 2 , 3 , 4 , 5 , 6 , 7
- Corresponding author
- Ting, Jenny P.-Y.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-04-12
- Volume
- 207
- Issue
- 5
- Pages
- 1045-1056
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2867287
- OpenAlex
- W2058590329
- Cited by
- 826
- References
- 44
- Citations by year
- 2026: 28 · 2025: 34 · 2024: 54 · 2023: 54 · 2022: 66 · 2021: 53 · 2020: 43 · 2019: 55 · 2018: 54 · 2017: 61 · 2016: 45 · 2015: 56 · 2014: 51 · 2013: 62 · 2012: 49
- FWCI
- 22.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- VTechWorks (Virginia Tech) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (2t32ar007416-25)
- National Cancer Institute (T32CA009156)
- National Institute of Allergy and Infectious Diseases (F32AI082895, U19AI077437, U19-AI077437-01)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK073338, P30‐DK34987, P30DK034987)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32-AR007416)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD046369)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NLRP3 inflammasome, colitis-associated colorectal cancer, inflammatory bowel disease, carcinogenesis, caspase-1, IL-1β, IL-18, NLRP3 knockout mice, NLRC4, hematopoietic cells, bone marrow reconstitution, DSS-induced colitis, azoxymethane, intestinal polyps
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Colitis, Colon, Cytoskeletal Proteins, Euthanasia, Humans, Neoplasms, Inflammatory Bowel Diseases, Gene Expression Regulation, Neoplastic, Mice, Knockout, Interleukin-18, Tumor Burden, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.